Advertisement

Topics

Companies Related to "Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion" [Most Relevant Company Matches] RSS

17:18 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Pharmacokinetic Dynamic Study Inhibitor Platelet Adhesion" Companies 1–25 of 2,400+

Relevant

Accumetrics

Accumetrics develops, manufactures, and markets the VerifyNow™ System, a comprehensive system for the assessment of platelet function. Modulation of platelet function plays a critical role in effectively treating cardiovascular, cerebrovascular, and peripheral vascular disease. VerifyNow is the only rapid platelet function test shown to correlate with clinical outcomes. The tests provide doctors...


Verax Biomedical

Verax is the producer of the Platelet PGD Test, the only test for bacterial contamination in platelets granted a Safety Measure claim by the FDA. The test can now also be used to extend the dating of apheresis platelets in plasma, the most common platelet type transfused in the U.S., from 5 to 7 days. This dating extension offers the opportunity for signif...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...


Platelet BioGenesis

Platelet BioGenesis is a venture-backed, development stage biotech company creating designer platelets (PLTs+™) as a new class of therapeutics. Platelet BioGenesis has developed and patented a scalable cGMP-compliant process to generate PLTs+™ from clinical grade induced pluripotent stem cells. The company was spun out of Harvard University and h...

Accumetrics Inc.

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics, Inc.

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...

BioCytex

Since the foundation of Biocytex in the early 90's in the close proximity of the University and Hospital Complex of La Timone / La Conception in Marseille (France), the need of standardization in flow cytometry analysis still remains a topic of concern. Inter-laboratory reproducibility, day to day reproducibility and positivity and/or negativity threshold determination are a real need that can be ...

Arno Therapeutics, Inc.

Arno Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes innovative products for the treatment of cancer patients. In addition to AR-67, Arno's lead clinical compound is AR-12, a potentially first-in-class, orally available PDK1 inhibitor that blocks the PI3K/Akt pathway and induces autophagy and the endoplasmi...

Adherex Technologies Incorporated

Adherex Technologies is a biotechnology company developing novel therapeutics based on cell adhesion technologies. Adherex is currently developing a portfolio of biologically active small molecules based on the cadherin family of cell adhesion molecules. Cadherins are the major biological glues that hold tissues intact. They play an important role in maintaining the integrity of tissues and barrie...

Acesis

Headquartered in Silicon Valley, Acesis (ă'sē-sĭs) is an enterprise software company providing hospitals and hospital systems with products that help improve quality and patient safety. The Acesis solution is a rich Internet, Dynamic Business Application, delivered as a subscription-based SaaS. Acesis is the de facto leader in dynamic performance ...

Medisse BV

Medisse BV is a leading innovator and developer of synthetic resorbable soft tissue implants. The Company’s first product, FlexiSurge Adhesion Barrier, is currently tested in a clinical study to obtain the clinical data needed for CE marking early in 2015. Medisse is also developing anti-adhesive technologies for use on other implantable medical devices ...

Shape Pharmaceuticals, Inc.

Shape Pharmaceuticals, Inc. is developing SHP-141, a novel, topical, “soft-drug” HDAC inhibitor for the treatment of patients with cutaneous T cell lymphoma (CTCL) and psoriasis. Shape has an ongoing Phase 1b clinical study in CTCL patients and has completed a Phase 1b clinical study in psoriasis patients. The development of SHP-141 is being supp...

SARcode Corporation

SAR 1118 is a potent novel small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; alpha L beta 2) antagonist that can be targeted against a broad range of ocular inflammatory conditions including dry eye, uveitis, and diabetic macular edema. LFA-1 is member of the integrin family of adhesion receptors found on the surface of all leukocytes and represents a therapeutic target o...

Accriva Diagnostics

Accriva Diagnostics is the result of ITC’s 2013 acquisition of Accumetrics. The combined strengths in coagulation monitoring (ITC) and platelet testing (Accumetrics) have created a leading point-of-care diagnostic company. The Accriva portfolio of products represent over 40 years of leadership and expertise in hemostasis management, including the deve...

R&D Systems Incorporated

R&D Systems produces and markets cytokines and adhesion molecules, corresponding antibodies, human and mouse ELISAs, as well as genes and probes.R&D Systems produces and markets cytokines and adhesion molecules, corresponding antibodies, human and mouse E

Synapse BV

Synapse BV is a working group within the Cardiovascular Research Institute Maastricht (CARIM) as well as a company within the Maastricht University Holding. It carries out developmental research in the field of the (patho-)physiology of haemostasis and thrombosis, operating in the niche between biochemistry and molecular biology on the one side and pharmaceutical- and clinical sciences on the othe...

SNBL USA, Ltd.

Headquartered in Everett, WA, SNBL USA, Ltd. offers a unique range of safety assessment services to support the drug development process. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, we offer programs ranging from regulatory toxicology to customized study designs and disease models. Our specialized capabi...

BIOCON, INC.

Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and colony management, research study applications, safety testing, custom antibody production or fully-compliant Good Laboratory Practices, BIOCON implements our client’s research initiative with dedicat...

Medisse

Established in 2006, Medisse develops flexible, resorbable implants for soft tissue applications. The Company’s unique FlexiSurge™ technology allows implants to maintain their functionality until almost fully resorbed. Medisse is able to engineer an implant’s resorption profile to precisely meet clinical requirements. Medisse’s lead product ...

Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals is a privately held biopharmaceutical company located in La Jolla, California. The company is a pioneer in the use of deuterium in medicinal chemistry, and is focused on the treatment of hyperkinetic movement disorders including Huntington’s disease, Tourette syndrome and tardive dyskinesia. Its lead compound, SD-809, is a novel ...

S*BIO Pte Ltd

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug ...

LCG Bioscience

LCG Bioscience is a dynamic Pan-European contract development organisation providing pre-clinical and clinical product development and safety services for the pharmaceutical and chemical industries.

ConfluentSurgical

Confluent Surgical Company Information Founded in August 1998, Confluent Surgical is a privately held medical device company that is pioneering the development of in-situ polymerized biomaterials. These materials have numerous surgical applications including adhesion prevention, tissue sealing, tissue hemostasis and drug-delivery. The synthetic materials are safe, simple to use, and allow the form...

Advanced Biomedical Research, Inc

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in the heart of New Jersey's pharmaceutical R&D corridor in Princeton, NJ. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and clinical data ...


More From BioPortfolio on "Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks